Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Milestone Pharmaceuticals Inc (MIST)

Milestone Pharmaceuticals Inc (MIST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Milestone Pharmaceuticals Inc 1111 DR. FREDERIK-PHILIPS BOULEVARD SUITE 420 MONTREAL A8 H4M 2X6 CAN

www.milestonepharma.com P: 514-336-0444

Description:

Milestone Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is engaged in developing and commercializing the investigational new drug etripamil for the treatment of cardiovascular indications. The company's lead product candidate consists of MSP-2017, a nasal spray. Milestone Pharmaceuticals Inc. is based in Montr'al, Canada.

Key Statistics

Overview:

Market Capitalization, $K 87,698
Enterprise Value, $K 73,938
Shares Outstanding, K 53,150
Annual Sales, $ 1,000 K
Annual Net Income, $ -59,690 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -13,610 K
EBIT, $ -61,100 K
EBITDA, $ -61,010 K
60-Month Beta 1.77
% of Insider Shareholders 10.40%
% of Institutional Shareholders 86.18%
Float, K 47,622
% Float 89.60%
Short Volume Ratio 0.29

Growth:

1-Year Return -55.80%
3-Year Return -71.20%
5-Year Return -90.83%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.32 on 03/21/24
Latest Earnings Date 05/09/24
Earnings Per Share ttm -1.39
EPS Growth vs. Prev Qtr 8.57%
EPS Growth vs. Prev Year -3.23%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

MIST Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -171.00%
Return-on-Assets % -64.45%
Profit Margin % -5,969.00%
Debt/Equity 0.00
Price/Sales 83.45
Price/Cash Flow N/A
Price/Book 3.07
Book Value/Share 0.50
Interest Coverage -22.41
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar